Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 37Neoplasm Metastasis 6Neoplasms by Site 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Diseases 2Anatomic Stage II Breast Cancer AJCC v8 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Locoregional Recurrence 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Leiomyosarcoma 1Head and Neck Neoplasms 1HR+/HER2- Breast Cancer 1HER2 Negative Breast Cancer Not Immediately Operated 1HER2 Negative Breast Cancer 1Glioma 1Glioblastoma 1

Interventions

Radiosurgery 23Temozolomide 14Magnetic Resonance Spectroscopy 14pembrolizumab 11Bevacizumab 11Nivolumab 10Ipilimumab 8Memantine 7Specimen Handling 6abemaciclib 5Radiotherapy 5Mental Status and Dementia Tests 5Blood Specimen Collection 5Radiation 4entrectinib 3Surveys and Questionnaires 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Lomustine 3trastuzumab deruxtecan 2trametinib 2pertuzumab 2osimertinib 2lenvatinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × ribociclib × 90 days × Clear all
NCT05843253 2026-05-29

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡